Clinical Trial to Treat Stage IV Cancer Patients
Clinical trial NCT06674538 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06674538
- Sponsor
- Moonshot Antibodies
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2027-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.